Understanding how scrub typhus affects blood vessel function

Pathogenic Mechanisms of Vascular Dysfunction in Scrub Typhus

NIH-funded research University of Texas Med Br Galveston · NIH-10881321

This study is looking at how the scrub typhus bacteria affects blood vessel function and the immune system in order to find better ways to treat people who get sick from it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston NIH-funded
Lab location1 site (Galveston, United States)
Project IDNIH-10881321 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which the scrub typhus bacterium, Orientia tsutsugamushi, causes vascular dysfunction. Using various mouse models that mimic human disease, the study aims to uncover how the immune response is altered during infection and how this leads to severe complications. The researchers are particularly focused on identifying specific markers and potential therapeutic targets that could improve treatment outcomes for affected individuals. By understanding these pathogenic mechanisms, the research hopes to pave the way for better infection control strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk of scrub typhus infection, particularly those living in endemic regions.

Not a fit: Patients who are not at risk of scrub typhus or those with non-vascular related complications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive measures for scrub typhus, potentially saving lives.

How similar studies have performed: Previous research has shown promise in understanding immune responses in similar infectious diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Galveston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.